Affimed rises after pricing upsized stock deal

Affimed NV

13/04/2022 14:14

** U.S.-listed shares of Affimed  AFMD.O  up ~3% after
German immuno-oncology firm raises more equity than targeted
    ** Co sold 22.5 mln shares at $4 for gross raise of $90 mln
 urn:newsml:reuters.com:*:nGNX5NHYKK
    ** Co marketed $75 mln deal upon launch after the bell Tues
    ** AFMD plans to use net offering proceeds to help fund R&D
for clinical and preclinical activities, among other uses
    ** Jefferies, SVB Leerink, Truist Secs and Wells Fargo jt
bookrunners
    ** Co has ~123.4 mln shares outstanding
    ** Stock has fallen 25% YTD through Tues close, and has lost
57% in past 12 months

 (Lance Tupper is a Reuters market analyst. The views expressed
are his own)
 ((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-332-219-1430))